Arrestins in Metabolic Regulation - Progress in Molecular Biology and Translational Science - page 415

57. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat
Med . 2004;10:355 - 361.
58. Nofsinger RR, Li P, Hong SH, et al. SMRT repression of nuclear receptors controls the
adipogenic set point and metabolic homeostasis. Proc Natl Acad Sci USA . 2008;105:
20021 - 20026.
59. Chen JD, Umesono K, Evans RM. SMRT isoforms mediate repression and anti-
repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA . 1996;93:
7567- 7571.
60. Tanaka T, Yamamoto J, Iwasaki S, et al. Activation of peroxisome proliferator-activated
receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates meta-
bolic syndrome. Proc Natl Acad Sci USA . 2003;100:15924- 15929.
61. Oliver Jr WR, Shenk JL, Snaith MR, et al. A selective peroxisome proliferator-activated
receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA .
2001;98:5306- 5311.
62. Kang J, Shi Y, Xiang B, et al. A nuclear function of beta-arrestin1 in GPCR signaling:
regulation of histone acetylation and gene transcription. Cell . 2005;123:833 - 847.
63. Zhuang LN, Hu WX, Zhang ML, et al. b -Arrestin-1 protein represses diet-induced
obesity. J Biol Chem . 2011;286:28396 - 28402.
64. Zhuang LN, Hu WX, Xin SM, Zhao J, Pei G. b -Arrestin-1 protein represses
adipogenesis and inflammatory responses through its interaction with peroxisome
proliferator-activated receptor- g (PPAR g ). J Biol Chem . 2011;286:28403 - 28413.
65. Choi JH, Banks AS, Estall JL, et al. Anti-diabetic drugs inhibit obesity-linked phosphor-
ylation of PPAR g by Cdk5. Nature . 2010;466:451- 456.
66. Choi JH, Banks AS, Kamenecka TM, et al. Antidiabetic actions of a non-agonist PPAR g
ligand blocking Cdk5-mediated phosphorylation. Nature . 2011;477:477 - 481.